You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous stem cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

Active, not recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 10, 2023

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

Recruiting
  • B-cell Lymphoma
  • ASCT+CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Morbidity, Long-term Side Effects and Quality of Life in

Recruiting
  • Germ Cell Tumor
    • Villejuif, France
      Gustave Roussy
    Jun 2, 2023

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    Based on Maintenance Therapy Post Autologous Stem Cell

    Recruiting
    • Multiple Myeloma
    • Autologous Stem Cell Transplant
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jul 27, 2022

    Muscle Stem Cell Quality in Atrophy

    Not yet recruiting
    • Muscle Weakness
    • +5 more
    • In vitro analyse
    • (no location specified)
    Oct 5, 2023

    Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

    Not yet recruiting
    • Multiple Myeloma
    • Budesonide EC
    • Placebo
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Jan 9, 2023

    Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 21, 2022

    T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)

    Withdrawn
    • T Cell Lymphoma
    • Brentuximab Vedotin
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    Feb 1, 2023

    T-Cell Lymphoma Trial in Saint Louis (Duvelisib, Peripheral blood draw)

    Recruiting
    • T-Cell Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 18, 2022

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

    Active, not recruiting
    • Multiple Myeloma
    • AL Amyloidosis
    • Siltuximab
    • The M.D. Anderson Symptom Inventory (MDASI)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

    Active, not recruiting
    • Scleroderma
    • +2 more
    • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
    • Tuebingen, Germany
      University Hospital Tuebingen; Department of oncology, hematolog
    May 16, 2022

    Frontline of ASCT in High-risk DLBCL

    Recruiting
    • Diffuse Large B Cell Lymphoma
      • Beijing, Beijing, China
        Peking University People's Hospital
      Apr 26, 2023

      Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

      Completed
      • Multiple Myeloma
      • allogeneic HSCT
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Sep 1, 2022

      Myeloma Trial in Philadelphia (Belantamab mafodotin)

      Recruiting
      • Myeloma
      • Belantamab mafodotin
      • Philadelphia, Pennsylvania
        Abramson Cancer Center at University of Pennsylvania
      Jun 13, 2022

      Myeloma Multiple, Lymphoma Trial in Maastricht (Vitamin C, Placebos)

      Completed
      • Myeloma Multiple
      • Lymphoma
      • Vitamin C
      • Placebos
      • Maastricht, Limburg, Netherlands
        MUMC+
      Apr 19, 2022

      Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Sep 29, 2022

      Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

      Terminated
      Has Results
      • Multiple Myeloma
      • New York, New York
      • +1 more
      Oct 3, 2022

      Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

      Recruiting
      • Systemic Lupus Erythematosus
      • Systemic Sclerosis
      • Depletion of CD3/CD19 in an autologous stem cell transplant
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      May 23, 2022